70,411 results on '"proteinúria"'
Search Results
52. Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products.
- Author
-
Sturgill, Kuan, Dicke, Katie, Zangardi, Mark, and Osborne, Kara
- Subjects
- *
PROTEINURIA , *BEVACIZUMAB , *TREATMENT effectiveness , *RETROSPECTIVE studies , *PHYSICIAN practice patterns , *MEDICAL records , *ACQUISITION of data , *RESEARCH methodology , *URINALYSIS , *PATIENT monitoring , *TUMORS - Abstract
Introduction: Proteinuria is a well-known toxicity of bevacizumab which can lead to kidney injury or nephrotic syndrome. There is little guidance on the frequency of monitoring and management of those that experience bevacizumab-induced proteinuria. Previous literature has suggested routine monitoring with every dose has limited clinical significance. Currently, there is no standardization of proteinuria monitoring at OhioHealth. Methods: This retrospective descriptive study included 100 adult patients who received at least 3 doses of a bevacizumab product for a malignant condition at any OhioHealth facility from April 15, 2022 to October 15, 2022. The primary outcome was to describe the average number of proteinuria tests ordered over the course of therapy. Results: Of the 100 patients evaluated, 91 received proteinuria monitoring during treatment with bevacizumab. The overall average number of tests completed per patient per month based on treatment period of bevacizumab was 1.51. Twenty-two of 91 patients (24%) developed grade 2+ proteinuria. Average time to first grade 2+ proteinuria event was 5.7 months. A history of baseline renal dysfunction or chronic kidney disease was the only predefined factor found to be significantly associated with developing grade 2+ proteinuria. The most common treatment modification following a grade 2+ proteinuria result was a delay in therapy. Conclusion: Proteinuria monitoring may not be necessary for short definitive courses of bevacizumab and closer monitoring should be considered in patients with baseline renal dysfunction or CKD. Future direction includes evaluating the cost of varying proteinuria tests and developing a recommendation for OhioHealth to standardize testing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
53. Confined placental mosaicism with trisomy 13 complicated by severe preeclampsia: A case report and literature review.
- Author
-
Ito, Takaaki, Takahashi, Hironori, Horie, Kenji, Nagayama, Shiho, Ogoyama, Manabu, and Fujiwara, Hiroyuki
- Subjects
- *
PREECLAMPSIA diagnosis , *PROTEINURIA , *CHORIONIC villus sampling , *FETAL growth retardation , *SECOND trimester of pregnancy , *CHROMOSOME abnormalities , *PRENATAL diagnosis , *FETAL ultrasonic imaging , *KARYOTYPES , *HYPERTENSION in pregnancy , *MOSAICISM , *AMNIOCENTESIS - Abstract
A 31‐year‐old primiparous woman underwent non‐invasive prenatal testing. The result was trisomy 13 (T13) positive. The chromosome 13 t‐statistics (Z‐score) was significantly high. The result of amniocentesis was normal karyotype (46,XX). Detailed ultrasound showed no fetal structural abnormalities. We suspected T13 confined placental mosaicism (CPM) and observed the course naturally. From the late second trimester, severe fetal growth restriction manifested followed by proteinuria and hypertension, diagnosing her with preeclampsia (PE). At 35 + 5 weeks, emergent cesarean section was required, yielding a 1480 g female infant. We sampled five locations of chorionic villi in the placenta. T13 cells dominated cells with normal karyotypes in all parts and the rate of trisomic cells ranged from 57% to 96%, which were generally high rate. None developed PE in reported T13 CPM cases and this is the first case of PE. The dominancy of T13 cells can be associated with PE development. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
54. Environmental Cadmium Exposure Induces an Increase in Systolic Blood Pressure by Its Effect on GFR.
- Author
-
Satarug, Soisungwan, Vesey, David A., Yimthiang, Supabhorn, Khamphaya, Tanaporn, Pouyfung, Phisit, and Đorđević, Aleksandra Buha
- Subjects
- *
CADMIUM , *SYSTOLIC blood pressure , *GLOMERULAR filtration rate , *PROTEINURIA , *ACQUISITION of data - Abstract
Chronic exposure to the nephrotoxic metal pollutant, cadmium (Cd), has been associated with hypertension, but the mechanism by which it raises blood pressure is not understood. We hypothesize that exposure to Cd reduces the glomerular filtration rate (GFR), which in turn causes a rise in blood pressure. Data were collected from 447 Thai subjects with a mean age of 51.1 years, of which 48.8% had hypertension, 15.4% had diabetes, and 6.9% had an estimated GFR (eGFR) below 60 mL/min/1.73 m2 (low eGFR). More than half (58.8%) and 23.9% had moderate and severe tubular proteinuria, respectively. The mean blood and urinary Cd concentrations were 2.75 and 4.23 µg/L, respectively. Doubling of body burden of Cd increased the prevalence odds ratios (POR) for low eGFR and severe tubular proteinuria 41% and 48%, respectively. The POR for hypertension rose twofold in those with blood Cd levels of 0.61–1.69 µg/L or urinary Cd excretion levels ≥ 0.98 µg/g creatinine. In the hypertensive group, the eGFR was inversely associated with age (β = −0.517), the Cd excretion rate (β = −0.177), and diabetes (β = −0.175). By mediation analysis, an increase in SBP was attributable totally to the effect of Cd on GFR. Thus, blood pressure appeared to rise as GFR fell. This finding is consistent with the well-known role of the kidney in long-term blood pressure regulation, and explains a universally high prevalence of hypertension among patients with low eGFR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
55. Prevalence and characteristics of bronchiectasis in ANCA-associated vasculitis: A systematic review and meta-analysis.
- Author
-
Yu Gu, Ting Zhang, Wenyan Zhu, Yang Han, and Juhong Shi
- Subjects
- *
BRONCHIECTASIS , *VASCULITIS , *MEDICAL information storage & retrieval systems , *PERIPHERAL neuropathy , *PROTEINURIA , *QUALITATIVE research , *RESEARCH funding , *ANTINEUTROPHIL cytoplasmic antibodies , *SEX distribution , *MICROSCOPIC polyangiitis , *META-analysis , *DESCRIPTIVE statistics , *SYSTEMATIC reviews , *MEDLINE , *ODDS ratio , *MEDICAL databases , *OXIDOREDUCTASES , *PROTEOLYTIC enzymes , *ONLINE information services , *CONFIDENCE intervals , *COMPARATIVE studies , *IMMUNOSUPPRESSION - Abstract
Objectives: This systematic review and meta-analysis aimed to investigate the prevalence of bronchiectasis (BR) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), the association of BR with manifestations of AAV, and the features of BR in AAV. Materials and methods: PubMed, EMBASE, Web of Science, and Cochrane Library were searched for publications related to AAV and BR in English from January 1, 1994, until December 7, 2022. The prevalence of BR was synthesized using random-effects models, and sources of heterogeneity were assessed by sensitivity and subgroup analyses. Odds ratios (ORs) were calculated using fixed-effects models to evaluate the association of BR with manifestations of AAV. Only qualitative synthesis was performed on the features of BR. Results: Studies that reported on the prevalence (n=24), the association (n=6), and the features (n=8) of BR were identified. The pooled overall prevalence of BR among AAV was 19% (95% confidence interval [CI]: 13-27%). The prevalence of patients with myeloperoxidase (MPO)-ANCA was significantly higher than those with proteinase 3-ANCA (28% vs. 13%, p=0.01). The female sex (OR=2.41), peripheral neuropathy (OR=4.58), MPO-ANCA (OR=4.73), and microscopic polyangiitis (OR=2.72) were associated with BR in AAV. Compared to individuals without BR, AAV-BR patients exhibited relatively lower levels of proteinuria. The diagnosis of BR could follow, be concomitant to, or precede that of AAV. However, BR usually did not respond to immunosuppressive therapy. Conclusion: AAV with BR is a common condition with special manifestations. The association of BR with AAV may not be accidental; however, the underlying pathogenesis remains to be clarified. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
56. Oxysterol-binding protein-like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria.
- Author
-
Duara, Joanne, Torres, Maria, Gurumani, Margaret, David, Judith Molina, Njeim, Rachel, Kim, Jin-Ju, Mitrofanova, Alla, Ge, Mengyuan, Sloan, Alexis, Müller-Deile, Janina, Schiffer, Mario, Merscher, Sandra, and Fornoni, Alessia
- Subjects
- *
KIDNEY glomerulus diseases , *CHRONIC kidney failure , *ENDOPLASMIC reticulum , *PROTEINURIA , *PSYCHOLOGICAL stress - Abstract
Chronic kidney disease (CKD) is associated with renal lipid dysmetabolism among a variety of other pathways. We recently demonstrated that oxysterol-binding protein-like 7 (OSBPL7) modulates the expression and function of ATP-binding cassette subfamily A member 1 (ABCA1) in podocytes, a specialized type of cell essential for kidney filtration. Drugs that target OSBPL7 lead to improved renal outcomes in several experimental models of CKD. However, the role of OSBPL7 in podocyte injury remains unclear. Using mouse models and cellular assays, we investigated the influence of OSBPL7 deficiency on podocytes. We demonstrated that reduced renal OSBPL7 levels as observed in two different models of experimental CKD are linked to increased podocyte apoptosis, primarily mediated by heightened endoplasmic reticulum (ER) stress. Although as expected, the absence of OSBPL7 also resulted in lipid dysregulation (increased lipid droplets and triglycerides content), OSBPL7 deficiency-related lipid dysmetabolism did not contribute to podocyte injury. Similarly, we demonstrated that the decreased autophagic flux we observed in OSBPL7-deficient podocytes was not the mechanistic link between OSBPL7 deficiency and apoptosis. In a complementary zebrafish model, osbpl7 knockdown was sufficient to induce proteinuria and morphological damage to the glomerulus, underscoring its physiological relevance. Our study sheds new light on the mechanistic link between OSBPL7 deficiency and podocyte injury in glomerular diseases associated with CKD, and it strengthens the role of OSBPL7 as a novel therapeutic target. NEW & NOTEWORTHY: OSBPL7 and ER stress comprise a central mechanism in glomerular injury. This study highlights a crucial link between OSBPL7 deficiency and ER stress in CKD. OSBPL7 deficiency causes ER stress, leading to podocyte apoptosis. There is a selective effect on lipid homeostasis in that OSBPL7 deficiency affects lipid homeostasis, altering cellular triglyceride but not cholesterol content. The interaction of ER stress and apoptosis supports that ER stress, not reduced autophagy, is the main driver of apoptosis in OSBPL7-deficient podocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
57. Proteinuria Assessment and Therapeutic Implementation in Chronic Kidney Disease Patients—A Clinical Audit on KDIGO ("Kidney Disease: Improving Global Outcomes") Guidelines.
- Author
-
Adelakun, Gabriela, Boesing, Maria, Mbata, Munachimso Kizito, Pasha, Zahra, Lüthi-Corridori, Giorgia, Jaun, Fabienne, Burkhalter, Felix, and Leuppi, Jörg D.
- Subjects
- *
CHRONIC kidney failure , *KIDNEY diseases , *PROTEINURIA , *ALBUMINURIA , *PEOPLE with diabetes - Abstract
Background/Objectives: Chronic kidney disease (CKD) is a major health problem with a rising prevalence due to comorbidities like diabetes and hypertension. The aim of this research was to audit the assessment and therapeutic management of proteinuria in CKD patients at the Cantonal Hospital Baselland (KSBL) in Switzerland and determine associations between patient comorbidities, rehospitalisation, death, and the quality of therapeutic management. Methods: We analysed data from 427 adults with CKD (eGFR < 45 mL/min/1.73 m2) hospitalised on the internal medicine ward in 2022. Results: The mean age was 85 years (range: 79–89), 45.9% were female, and the median eGFR was 32.8 mL/min/1.73 m2 (range: 25–40). Proteinuria assessment was performed in 120 (28.1%) patients (the ProtU group), and a corresponding treatment was prescribed in 59%. The ProtU group had a higher quota of patients with diabetes (44.1% vs. 33%, p = 0.048) and obesity (21.2% vs. 12.5%, p = 0.039) when compared to the group without proteinuria assessment (the Ustix group). Twelve-month survival was not significantly different between the groups (HR: 0.75; 95% CI: 0.488–1.154; p-value = 0.191). However, survival was significantly better in patients who received an antiproteinuric treatment compared to those who did not (HR: 0.30; 95% CI: 0.121–0.0761; p = 0.011). Conclusions: Improvements need to be made in managing CKD at the KSBL in accordance with the guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
58. Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study.
- Author
-
Huang, Kuan-Ju, Chang, Wen-Chun, Chen, Chi-Hau, Lin, Wei-Chen, Pan, William Wei-Lin, Hsieh, Hao-I., Hsieh, Yu-Hsiung, Wei, Lin-Hung, and Sheu, Bor-Ching
- Subjects
- *
CHRONIC kidney failure , *NEOVASCULARIZATION inhibitors , *GYNECOLOGIC cancer , *ANTINEOPLASTIC agents , *DIET in disease - Abstract
Proteinuria is a common adverse event arising from treatment with bevacizumab, requiring diagnostic testing via 24-h urine collection. However, this method is cumbersome. We assessed urine screenings in gynecologic cancer patients from February 2021 to May 2022. Along with a simple urine dipstick (UD), the urine microalbumin, total protein, and creatinine were measured and calculated as the urine albumin to creatinine ratio (UACR) and the urine protein to creatinine ratio (UPCR), which were further adjusted through the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations to be estimated and correlated with 24-h urine total protein content. The incremental cost-effectiveness ratio was used for cost analysis. There were 129 urine samples from 36 patients. The sensitivity and specificity for the UACR were 0.56 and 0.97, and for the UPCR, 0.71 and 0.88, respectively. The 24-h TP correlated strongly with the UACR (r = 0.75; p < 0.001) and UPCR (r = 0.79; p < 0.001) and fair for the simple UD (r = 0.35; p < 0.001). The UPCR saves one unnecessary 24-h urine test for less than a dollar compared to a simple UD. The results indicate that using the UPCR could enhance diagnostic accuracy, lower costs, and reduce unnecessary 24-h urine sampling. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
59. Hypertensive Disorders of Pregnancy: Diagnosis, Management and Timing of Birth.
- Author
-
İnan, Cihan, Uygur, Lütfiye, Alpay, Verda, Ayaz, Reyhan, Uysal, Nihal Şahin, Biri, Aydan, Yıldırım, Gökhan, and Sayın, Niyazi Cenk
- Subjects
- *
PROTEINURIA , *INFANT mortality , *DISEASE management , *MATERNAL mortality , *LABOR (Obstetrics) , *PREGNANCY outcomes , *ANTIHYPERTENSIVE agents , *HYPERTENSION in pregnancy , *DISEASES , *PREECLAMPSIA , *PREGNANCY complications , *TIME , *CHILDBIRTH - Abstract
Hypertensive disorders of pregnancy are significant contributors to maternal and perinatal morbidity and mortality. The definition, classification, and management of these disorders have evolved over time. Notably, the disease classification enables caretakers to manage the disease as well as safeguard maternal and fetal health. The approach and management for pregnancies with gestational and chronic hypertension or pre-eclampsia with or without severe features should be adequately elucidated to mitigate adverse perinatal outcomes. This review aimed to present the most recent definition and classification of hypertensive disorders of pregnancy to address their management, determine the optimal timing of birth, and establish short- and long-term follow-up protocols following parturition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
60. 703 例次移植肾穿刺活组织检查的病理诊断分析.
- Author
-
涂宇豪, 郭志良, 萨如拉, 朱兰, 郭晖, and 陈刚
- Abstract
Objective To summarize the occurrence of complications in renal graft biopsy, and to analyze the indications for puncture and types of pathological diagnosis. Methods The data of 703 samples of ultrasound-guided renal graft biopsy from 644 kidney transplant recipients from January 1, 2017, to December 31, 2022 was retrospectively analyzed. The puncture qualification rate, complications, indicative biopsy indications and pathological diagnosis types were analyzed. The application of surveillance biopsy and pathological diagnosis were also analyzed. Results The qualification rate of renal tissue puncture biopsy was 99.9%, and the complications of puncture bleeding included one sample of perinephric hematoma and one sample of hematuria. Increased serum creatinine (76.8%) and proteinuria (13.8%) were the main indications for puncture, and 48 samples (6.8%) were surveillance biopsy for the assessment of therapeutic effects. A total of 399 samples of pathological diagnosis of rejection, including 293 samples of cellular rejection reaction, 60 samples of antibody rejection reaction, and 46 samples of mixed rejection reaction. One hundred and ninety-five samples of recurrence or new-onset kidney disease, mainly including 144 samples of IgA nephropathy and 42 samples of focal segmental glomerulosclerosis. Fifty-seven samples of infection related kidney disease, including 56 samples of BK virus-associated nephropathy (BKVAN). Thirty-one samples of calcineurin inhibitor (CNI) nephrotoxicity injury, including 15 samples of acute CNI nephrotoxicity injury and 16 samples of chronic CNI nephrotoxicity injury. Forty-five samples for other diagnoses. Conclusions The success rate and safety of renal graft biopsy are high, and at present, cellular rejection reaction is still the main pathological diagnosis of indicative biopsy for renal graft. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
61. Diagnostic accuracy of ANCA serology in ANCA‐associated vasculitis with renal involvement.
- Author
-
Cohen, Adrienne, Weerasinghe, Nethmi, Lemmert, Karla, de Malmanche, Theo, and Myint, Thida
- Subjects
- *
VASCULITIS , *BIOPSY , *PROTEINURIA , *RISK assessment , *RECEIVER operating characteristic curves , *ANTINEUTROPHIL cytoplasmic antibodies , *IMMUNOGLOBULINS , *RETROSPECTIVE studies , *FLUORESCENT antibody technique , *CHEMILUMINESCENCE assay , *HEMATURIA , *ACUTE kidney failure , *DESCRIPTIVE statistics , *DECISION making , *GLOMERULONEPHRITIS , *LONGITUDINAL method , *PROTEOLYTIC enzymes , *OXIDOREDUCTASES , *IMMUNOASSAY , *CONFIDENCE intervals , *SENSITIVITY & specificity (Statistics) , *KIDNEYS , *BLOOD , *DISEASE risk factors - Abstract
Background: Pauci‐immune glomerulonephritis (GN) due to antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is a common cause of crescentic GN. Despite advances in treatment, rates of mortality and progression to end‐stage kidney disease remain high. Renal involvement is diagnosed by histological examination of kidney tissue. Serum ANCAs play a significant role in AAV; however, the value of serum ANCA quantification to predict renal involvement is not well‐established. Aim: We aimed to evaluate the diagnostic accuracy of serum ANCA titres in diagnosing AAV with renal involvement. Methods: We conducted a retrospective study of consecutive native kidney biopsies reported at our centre from 2016 to 2021. We included all adults who had both a kidney biopsy and ANCA serology. ANCA serology was tested using indirect immunofluorescence with reporting of titres. Antibodies to proteinase 3 and myeloperoxidase were measured using a chemiluminescent immunoassay. Results: Eight hundred and forty‐eight native kidney biopsies were reported during the study period. Five hundred and seven cases were included. The biopsy prevalence of pauci‐immune GN in paired samples was 41/507 (8.1%). Most of the cohort had haematuria (66.6%), proteinuria (93.4%) and/or acute kidney injury (65.0%). A positive ANCA at any titre demonstrated a sensitivity of 97.6% and a specificity of 71.2% for a diagnosis of pauci‐immune GN. The area under the curve for the receiver operator characteristic was 0.93 (95% confidence interval [CI]: 0.89–0.97). A cutoff ANCA titre of 1:160 provided the optimum balance between a sensitivity of 75.6% (95% CI: 59.7%–87.6%) and a specificity of 94.0% (95% CI: 91.6%–96.0%). Conclusions: ANCA titres are highly predictive of pauci‐immune GN in the appropriate context. While serum ANCA quantitation may not replace renal biopsy, reporting will assist in the decision to start treatment early for patients with organ or life‐threatening disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
62. Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta‐Analysis of the Control Arms of Randomized Controlled Trials.
- Author
-
Figueroa‐Parra, Gabriel, Cuéllar‐Gutiérrez, María C., González‐Treviño, Mariana, Sanchez‐Rodriguez, Alain, Flores‐Gouyonnet, Jaime, Meade‐Aguilar, José A., Prokop, Larry J., Murad, M. Hassan, Dall'Era, María, Rovin, Brad H., Houssiau, Frédéric, Tamirou, Farah, Fervenza, Fernando C., Crowson, Cynthia S., Putman, Michael S., and Duarte‐García, Alí
- Subjects
- *
MORTALITY , *BIOPSY , *COMBINATION drug therapy , *PROTEINURIA , *LUPUS nephritis , *IMMUNOSUPPRESSIVE agents , *DEATH , *RESEARCH funding , *PATHOLOGIC complete response , *MYCOPHENOLIC acid , *DRUG therapy , *INFECTION , *TREATMENT effectiveness , *META-analysis , *PREDNISONE , *DESCRIPTIVE statistics , *SYSTEMATIC reviews , *DOSE-effect relationship in pharmacology , *CONFIDENCE intervals , *GLUCOCORTICOIDS , *KIDNEYS , *CYCLOPHOSPHAMIDE , *THERAPEUTICS - Abstract
Objective: Our objective was to evaluate the effect of glucocorticoid regimens on renal response, infections, and mortality among patients with lupus nephritis (LN). Methods: We performed a systematic review and meta‐analysis of the control arms of randomized clinical trials (RCTs). We included RCTs of biopsy‐proven LN that used a protocolized regimen of glucocorticoids in combination with mycophenolic acid analogs or cyclophosphamide and reported the outcomes of complete response (CR), serious infections, and death. The starting dosage of glucocorticoids, tapering method, and administration of glucocorticoid pulses were abstracted. Meta‐analysis of proportions, meta‐regression, and subgroup meta‐analysis were performed at 6 and 12 months for all outcomes. Results: Fifty RCT arms (3,231 patients with LN) were included. The predicted rates of CR, serious infections, and death when starting on oral prednisone at 25 mg/day without pulses were 19.5% (95% confidence interval [CI] 7.3–31.5), 3.2% (95% CI 2.4–4.0), and 0.2% (95% CI 0.0–0.4), respectively. Starting on prednisone at 60 mg/day (without pulses) increased the rates to 34.6% (95% CI 16.9–52.3), 12.1% (95% CI 9.3–14.9), and 2.7% (95% CI 0.0–5.3), respectively. Adding glucocorticoid pulses increased the rates of CR and death but not serious infections. We observed a dose–response gradient between the initial glucocorticoid dosage and all the outcomes at six months after accounting for the administration of glucocorticoid pulses, underlying immunosuppressant, and baseline proteinuria. Conclusion: A higher exposure to glucocorticoids during the initial therapy of LN was associated with better renal outcomes at the cost of increased infections and death. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
63. Correlation of light and electron microscopic morphometric parameters of glomerular capillaries with serum creatinine and proteinuria.
- Author
-
Boruah, Dibyajyoti, Kashif, A.W., Chakrabarty, Barun Kumar, Harikrishnan, Sarika, and Sen, Arijit
- Subjects
- *
TRANSMISSION electron microscopes , *TOLUIDINE blue , *RENAL biopsy , *WASTE products , *BASAL lamina , *KIDNEYS - Abstract
Waste products in the bloodstream are filtered by the glomerular capillaries in the kidneys and excreted into the urine. When making a differential diagnosis of kidney diseases, structural assessment of glomeruli using histological, ultrastructural, and immunological studies is crucial. This study assessed the microscopic and ultrastructural morphometric parameters of glomerular capillaries and examined their correlation with serum creatinine and proteinuria. A total of 60 kidney biopsy cases received by the transmission electron microscope (TEM) laboratory for diagnosis were included in the study. Toluidine blue stained 300 nm thick sections of TEM tissue blocks were scanned for glomerular morphometry by a whole slide imaging system, and the estimation of Bowman's capsule (BC) area, glomerular capillary lumen diameter (GCLD), glomerular capillary density (GCD), glomerular capillary surface area density (GCSA), and percentage of glomerular capillary lumen space (%GCLS) was performed with QuPath software. TEM images of 70 nm thick sections were used for the evaluation of endothelial fenestration diameter (EFD), glomerular basement membrane (GBM) thickness, and podocyte foot process (PFP) effacement. Proteinuria and serum creatinine showed positive correlations with GBM thickness and PFP effacement. Negative correlations of serum creatinine were observed with EFD, %GCLS, and GCSA. Hence, glomerular filtration is greatly affected by the total area of the glomerular capillary surface and structural changes of GBM. Reduction of glomerulus filtration due to foot process effacement and thickening of GBM results in damage to the filtration barrier leading to the leakage of plasma protein into urine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
64. Dyslipidemia in children with chronic kidney disease—findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study.
- Author
-
Mencarelli, Francesca, Azukaitis, Karolis, Kirchner, Marietta, Bayazit, Aysun, Duzova, Ali, Canpolat, Nur, Bulut, Ipek Kaplan, Obrycki, Lukasz, Ranchin, Bruno, Shroff, Rukshana, Caliskan, Salim, Candan, Cengiz, Yilmaz, Alev, Özcakar, Zeynep Birsin, Halpay, Harika, Kiyak, Aysel, Erdogan, Hakan, Gellermann, Jutta, Balat, Ayse, and Melk, Anette
- Subjects
- *
CROSS-sectional method , *PROTEINURIA , *PREPROCEDURAL fasting , *HYPERLIPIDEMIA , *RESEARCH funding , *SECONDARY analysis , *CREATININE , *DISEASE duration , *BODY mass index , *LIPIDS , *DESCRIPTIVE statistics , *AGE distribution , *DIASTOLIC blood pressure , *ALBUMINS , *TRIGLYCERIDES , *REGRESSION analysis , *GLOMERULAR filtration rate , *SERUM albumin , *DISEASE risk factors , *CHILDREN ,CHRONIC kidney failure complications - Abstract
Background: Dyslipidemia is an important and modifiable risk factor for CVD in children with CKD. Methods: In a cross-sectional study of baseline serum lipid levels in a large prospective cohort study of children with stage 3–5 (predialysis) CKD, frequencies of abnormal lipid levels and types of dyslipidemia were analyzed in the entire cohort and in subpopulations defined by fasting status or by the presence of nephrotic range proteinuria. Associated clinical and laboratory characteristics were determined by multivariable linear regression analysis. Results: A total of 681 patients aged 12.2 ± 3.3 years with a mean eGFR of 26.9 ± 11.6 ml/min/1.73 m2 were included. Kidney diagnosis was classified as CAKUT in 69%, glomerulopathy in 8.4%, and other disorders in 22.6% of patients. Nephrotic range proteinuria (defined by a urinary albumin/creatinine ratio > 1.1 g/g) was present in 26.9%. Dyslipidemia was found in 71.8%, and high triglyceride (TG) levels were the most common abnormality (54.7%). Fasting status (38.9%) had no effect on dyslipidemia status. Except for a significant increase in TG in more advanced CKD, lipid levels and frequencies of dyslipidemia were not significantly different between CKD stages. Hypertriglyceridemia was associated with younger age, lower eGFR, shorter duration of CKD, higher body mass index (BMI-SDS), lower serum albumin, and higher diastolic blood pressure. Conclusions: Dyslipidemia involving all lipid fractions, but mainly TG, is present in the majority of patients with CKD irrespective of CKD stage or fasting status and is significantly associated with other cardiovascular risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
65. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
- Author
-
Ueda, Chika, Horinouchi, Tomoko, Inoki, Yuta, Ichikawa, Yuta, Tanaka, Yu, Kitakado, Hideaki, Kondo, Atsushi, Sakakibara, Nana, Nagano, China, Yamamura, Tomohiko, Fujimura, Junya, Kamiyoshi, Naohiro, Ishimori, Shingo, Ninchoji, Takeshi, Kaito, Hiroshi, Shima, Yuko, Iijima, Kazumoto, Nozu, Kandai, and Yoshikawa, Norishige
- Subjects
- *
PROTEINURIA , *RENIN-angiotensin system , *RETROSPECTIVE studies , *DISEASE remission , *DESCRIPTIVE statistics , *SEVERITY of illness index , *GLOMERULONEPHRITIS , *GLOMERULAR filtration rate , *SYMPTOMS , *CHILDREN - Abstract
Background: Membranoproliferative glomerulonephritis (MPGN) can be divided into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G), which includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). These conditions result from abnormalities in different complement pathways and may lead to different prognoses. However, there are limited studies describing the respective clinical courses. Methods: In this study, Japanese pediatric patients diagnosed with MPGN based on kidney biopsies conducted between February 2002 and December 2022 were reclassified as having IC-MPGN or C3G (DDD or C3GN). We retrospectively analyzed the clinical characteristics and outcomes of these patients. Results: Out of 25 patients with MPGN, three (12.0%) were diagnosed with DDD, 20 (80.0%) with C3GN, and two (8.0%) with IC-MPGN. There were 13 (65.0%) patients and one (33.3%) patient in remission after treatment for C3GN and DDD, respectively, and no patients with IC-MPGN achieved remission. The median follow-up period was 5.3 (2.5–8.9) years, and none of the patients in either group progressed to an estimated glomerular filtration rate < 15 ml/min/1.73 m2. Patients with C3GN presenting mild to moderate proteinuria (n = 8) received a renin-angiotensin system inhibitor (RAS-I) alone, and these patients exhibited a significant decrease in the urinary protein creatinine ratio and a notable increase in serum C3 levels at the last follow-up. Conclusions: Most patients with MPGN were diagnosed with C3GN. The remission rate for C3GN was high, and no patients developed kidney failure during the approximately 5-year follow-up. Additionally, patients with C3GN with mild to moderate proteinuria had good outcomes with RAS-I alone, but continued vigilance is necessary to determine long-term prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
66. Early diagnosis of solitary functioning kidney: comparing the prognosis of kidney agenesis and multicystic dysplastic kidney.
- Author
-
Flogelova, Hana, Bouchalova, Katerina, Smakal, Oldrich, Halek, Jan, Langova, Katerina, and Cizkova, Katerina
- Subjects
- *
PROTEINURIA , *NEWBORN screening , *KIDNEY abnormalities , *RESEARCH funding , *HYPERTENSION , *DESCRIPTIVE statistics , *CYSTIC kidney disease , *LONGITUDINAL method , *EARLY diagnosis , *COMPARATIVE studies , *GLOMERULAR filtration rate , *BIOMARKERS , *CHILDREN - Abstract
Background: Individuals with congenital solitary functioning kidney (SFK) are at an increased risk of kidney damage. According to some studies, the risk is higher in unilateral kidney agenesis (UKA) than in unilateral multicystic dysplastic kidney (UMCDK). We hypothesized that with early detection of children with UKA and UMCDK, there would be no difference in the presence of hypertension, proteinuria, and reduced glomerular filtration rate (GFR) between UKA and UMCDK. Methods: Based on a long-term follow-up protocol, we evaluated a cohort of 160 children followed from birth for SFK (84 with UKA and 76 with UMCDK) detected by prenatal or routine neonatal ultrasound screening. Hypertension, proteinuria, and reduced GFR were monitored as markers of kidney damage. We compared the characteristics and outcomes of the subgroups of children with UKA and UMCDK. Results: GFR was reduced in 42 (26.2%) children, of whom 41 showed only mild reduction. Hypertension and proteinuria were found in 22 (13.8%) and 14 (8.8%) children, respectively. Combined kidney damage was present in 57 (35.6%) children. The UMCDK and UKA subgroups differed in GFR at final examination, with UMCDK patients being significantly more likely to have normal GFR compared to UKA patients (82% vs. 67%; p = 0.039). Conclusions: One third of the children showed signs of SFK damage, albeit mild. Patients with UKA had reduced GFR significantly more often than those with UMCDK, but did not differ in the rates of hyperfiltration injury or congenital anomalies of the kidneys and urinary tract (CAKUT) in SFK. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
67. Nail-patella syndrome with nephropathy in a de novo LMX1B mutation: triangular lunula of the thumb and lack of finger creases as clues.
- Author
-
Banno, Yoshinori, Ikemiyagi, Masako, Hamada, Riku, Nozu, Kandai, Matsuoka, Kentaro, and Kamimaki, Isamu
- Subjects
- *
FINGER abnormalities , *FINGER physiology , *PROTEINS , *PROTEINURIA , *BIOPSY , *TRANSCRIPTION factors , *THUMB , *NAIL-patella syndrome , *GENETIC mutation , *KIDNEY diseases - Abstract
Nail-patella syndrome (NPS) is an autosomal dominant disease caused mostly by mutations in the LMX1B gene and is characterized by hypoplastic nails, hypoplastic patella, elbow deformities, glaucoma, and nephropathy, sometimes leading to kidney failure. The combination and the severity of symptoms vary greatly from patient to patient. Because a kidney biopsy may show nonspecific findings, patients with nephropathy alone may not be diagnosed without undergoing genetic testing. We examined the case of a 6-year-old girl with persistent high proteinuria who was not diagnosed by kidney biopsy but had a diagnosis of a de novo mutation in the LMX1B gene following genetic testing. Retrospectively, only the thumbs showed triangular lunulae, while the third and fourth fingers lacked skin creases over the distal interphalangeal joints, which is subtle but characteristic of NPS. Notifying pediatric nephrologists of these findings can help avoid unnecessary kidney biopsies and lead to early detection of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
68. A case of novel NFKB2 variant with hypertensive emergency and nephrotic syndrome leading to CKD 5D.
- Author
-
Nagata, Toru, Nakagawa, Kenji, Tsurumi, Fumitoshi, Watanabe, Ken, Endo, Tomomi, and Hata, Atsuko
- Subjects
- *
TREATMENT of chronic kidney failure , *NF-kappa B , *PERITONEAL dialysis , *PROTEINURIA , *KIDNEY function tests , *HYPERTENSIVE crisis , *HYPERTENSION , *AGAMMAGLOBULINEMIA , *CHRONIC kidney failure , *NEPHROTIC syndrome , *GENETIC variation , *DYSPNEA , *DISEASE complications - Abstract
Nuclear factor kappa B (NF-κB) family plays a central role in the human immune system. Heterozygous variants in NFKB2 typically cause immunodeficiency with various degrees of central adrenal insufficiency, autoimmunity, and ectodermal dysplasia. No reported case has presented kidney failure as an initial symptom. Moreover, documentation of kidney involvement of this disease is limited. Case diagnosis: A 2-year-old female who presented with dyspnea and hypertensive emergency in the setting of new-onset nephrotic syndrome with acute-on chronic kidney injury with resultant chronic kidney disease (CKD) was found to have a novel heterozygous N-terminal variant in NFKB2 (c.880del: p. Tyr294Ilefs*4) with mild hypogammaglobulinemia, but no adrenal insufficiency or ectodermal dysplasia. She became dialysis-dependent during her initial hospitalization and developed CKD stage 5D, requiring continued peritoneal dialysis. She is currently awaiting kidney transplantation. Conclusions: Whether nephrotic syndrome or kidney injury or failure is the primary symptom of this variant or secondary to some event remains unknown. Further case accumulation is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
69. WT1-related disorders: more than Denys-Drash syndrome.
- Author
-
Lopez-Gonzalez, Mercedes and Ariceta, Gema
- Subjects
- *
GENETICS of disease susceptibility , *SEX differentiation disorders , *STEROIDS , *PROTEINURIA , *RISK assessment , *CONSERVATIVE treatment , *KIDNEY transplantation , *DENYS-Drash syndrome , *GENITALIA tumors , *SEVERITY of illness index , *NEPHROTIC syndrome , *PARADIGMS (Social sciences) , *WAGR syndrome , *GENETIC mutation , *NEPHROBLASTOMA , *INDIVIDUALIZED medicine , *PHENOTYPES , *GENOTYPES , *DRUG resistance , *HEALTH care teams , *INTEGRATED health care delivery , *DISEASE risk factors , *SYMPTOMS - Abstract
Historically, specific mutations in WT1 gene have been associated with distinct syndromes based on phenotypic characteristics, including Denys-Drash syndrome (DDS), Frasier syndrome (FS), Meacham syndrome, and WAGR syndrome. DDS is classically defined by the triad of steroid-resistant nephrotic syndrome (SRNS) onset in the first year of life, disorders of sex development (DSD), and a predisposition to Wilms tumor (WT). Currently, a paradigm shift acknowledges a diverse spectrum of presentations beyond traditional syndromic definitions. Consequently, the concept of WT1-related disorders becomes more precise. A genotype–phenotype correlation has been established, emphasizing that the location and type of WT1 mutations significantly influence the clinical presentation, the condition severity, and the chronology of patient manifestations. Individuals presenting with persistent proteinuria, with or without nephrotic syndrome, and varying degrees of kidney dysfunction accompanied by genital malformations should prompt suspicion of WT1 mutations. Recent genetic advances enable a more accurate estimation of malignancy risk in these patients, facilitating a conservative nephron-sparing surgery (NSS) approach in select cases, with a focus on preserving residual kidney function and delaying nephrectomies. Other key management strategies include kidney transplantation and addressing DSD and gonadoblastoma. In summary, recent genetic insights underscore the imperative to implement individualized, integrated, and multidisciplinary management strategies for WT1-related disorders. This approach is pivotal in optimizing patient outcomes and addressing the complexities associated with these diverse clinical manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
70. Complete Remission of Renal Scarring in Follow-Up DMSA Renal Scintigraphy After Urinary Tract Infection.
- Author
-
Hosokawa, Takahiro and Uchiyama, Mayuki
- Subjects
- *
URINARY tract infections , *PROTEINURIA , *SEX distribution , *HYPERTENSION , *VESICO-ureteral reflux , *FISHER exact test , *TECHNETIUM compounds , *DISEASE remission , *AGE distribution , *SEVERITY of illness index , *RETROSPECTIVE studies , *MANN Whitney U Test , *DESCRIPTIVE statistics , *NUCLEAR medicine , *MEDICAL records , *ACQUISITION of data , *KIDNEY diseases , *DATA analysis software , *CASE studies , *RADIONUCLIDE imaging - Abstract
Our study aimed to investigate the association between the characteristics of patients/images and complete remission of renal scarring shown in the first chronic phase Technetium-99m dimercaptosuccinic acid (DMSA) renal scintigraphy images in children with urinary tract infection (UTI). Fifty children, who underwent the chronic phase of DMSA scintigraphy more than twice following UTI diagnosis and had renal scarring in the first chronic phase DMSA renal scintigraphy, were enrolled. They were classified into 2 groups: with and without complete remission of renal scarring on the second chronic phase DMSA renal scintigraphy. Renal scarring was classified into 3 grades based on severity per the image findings. Seven cases had complete remission from renal scarring. There were significant differences in age and severity. Renal scarring might be completely reversed in young children without severe findings on DMSA renal scintigraphy. Additional chronic phase examination may aid in follow-up completion and patients' peace of mind. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
71. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants.
- Author
-
Furlano, Mónica, Pilco-Teran, Melissa, Pybus, Marc, Martínez, Víctor, Aza-Carmona, Miriam, Peris, Asunción Rius, Pérez-Gomez, Vanessa, Berná, Gerson, Mazon, Jaime, Hernández, Jonathan, Arizón, Leonor Fayos de, Viera, Elizabet, Gich, Ignasi, Pérez, Hugo Vergara, Gomá-Garcés, Elena, Dolon, José Luis Albero, Ars, Elisabet, and Torra, Roser
- Subjects
- *
CYSTIC kidney disease , *RENAL replacement therapy , *GLOMERULAR filtration rate , *CHRONIC kidney failure , *PROTEINURIA - Abstract
Background Clinical variability among individuals with heterozygous pathogenic/likely pathogenic (P/LP) variants in the COL4A3 / COL4A4 genes (also called autosomal dominant Alport syndrome or COL4A3/COL4A4 -related disorder) is huge; many individuals are asymptomatic or show microhematuria, while others may develop proteinuria and chronic kidney disease (CKD). The prevalence of simple kidney cysts (KC) in the general population varies according to age, and patients with advanced CKD are prone to have them. A possible association between heterozygous COL4A3, COL4A4 and COL4A5 P/LP variants and KC has been described in small cohorts. The presence of KC in a multicenter cohort of individuals with heterozygous P/LP variants in the COL4A3 / COL4A4 genes is assessed in this study. Methods We evaluated the presence of KC by ultrasound in 157 individuals with P/LP variants in COL4A3 (40.7%) or COL4A4 (53.5%) without kidney replacement therapy. The association between presence of KC and age, proteinuria, estimated glomerular filtration rate (eGFR) and causative gene was analyzed. Prevalence of KC was compared with historical case series in the general population. Results Half of the individuals with P/LP variants in COL4A3 / COL4A4 showed KC, which is a significantly higher percentage than in the general population. Only 3.8% (6/157) had cystic nephromegaly. Age and eGFR showed an association with the presence of KC (P < .001). No association was found between KC and proteinuria, sex or causative gene. Conclusions Individuals with COL4A3 / COL4A4 P/LP variants are prone to develop KC more frequently than the general population, and their presence is related to age and to eGFR. Neither proteinuria, sex nor the causative gene influences the presence of KC in these individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
72. Guidelines for clinical evaluation of chronic kidney disease in early stages: AMED research on regulatory science of pharmaceuticals and medical devices.
- Author
-
Sugawara, Yuka, Kanda, Eiichiro, Hamano, Takayuki, Itano, Seiji, Okada, Hirokazu, Tomori, Koji, Watanabe, Yusuke, Asakura, Wataru, Isaka, Yoshitaka, Iseki, Kunitoshi, Usui, Tomoko, Suzuki, Yusuke, Tanaka, Mototsugu, Nishimura, Rimei, Fukami, Kei, Matsushita, Kunihiro, Wada, Jun, Watada, Hirotaka, Ueki, Kohjiro, and Kashihara, Naoki
- Subjects
- *
DIABETIC nephropathies , *MEDICAL sciences , *CHRONIC kidney failure , *DISEASE risk factors , *ALBUMINURIA - Abstract
Background: For the development of pharmaceutical products in kidney field, appropriate surrogate endpoints which can predict long-term prognosis are needed as an alternative to hard endpoints, such as end-stage kidney disease. Though international workshop has proposed estimated glomerular filtration rate (GFR) slope reduction of 0.5–1.0 mL/min/1.73 m /year and 30% decrease in albuminuria/proteinuria as surrogate endpoints in early and advanced chronic kidney disease (CKD), it was not clear whether these are applicable to Japanese patients. Methods: We analyzed J-CKD-DB and CKD-JAC, Japanese databases/cohorts of CKD patients, and J-DREAMS, a Japanese database of patients with diabetes mellitus to investigate the applicability of eGFR slope and albuminuria/proteinuria to the Japanese population. Systematic review on those endpoints was also conducted including the results of clinical trials published after the above proposal. Results: Our analysis showed an association between eGFR slope and the risk of end-stage kidney disease. A 30% decrease in albuminuria/proteinuria over 2 years corresponded to a 20% decrease in the risk of end-stage kidney disease patients with baseline UACR ≥ 30 mg/gCre or UPCR ≥ 0.15 g/gCre in the analysis of CKD-JAC, though this analysis was not performed on the other database/cohort. Those results suggested similar trends to those of the systematic review. Conclusion: The results suggested that eGFR slope and decreased albuminuria/proteinuria may be used as a surrogate endpoint in clinical trials for early CKD (including diabetic kidney disease) in Japanese population, though its validity and cutoff values must be carefully considered based on the latest evidence and other factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
73. Haematuria and proteinuria in childhood.
- Author
-
Lunn, Andrew and Forbes, Thomas A.
- Subjects
KIDNEY abnormalities ,PROTEINURIA ,PATIENTS' families ,URINARY tract infections ,MEDICAL personnel ,HEMATURIA ,PEDIATRICS ,NEPHROTIC syndrome ,GENITOURINARY organ abnormalities ,PATIENT-professional relations ,URINALYSIS ,KIDNEY diseases ,ALGORITHMS ,CHILDREN - Abstract
Haematuria and proteinuria are common findings on urinalysis in childhood. They usually occur in either children with specific symptoms e.g. macroscopic haematuria or nephrotic syndrome, or in those who have non-specific symptoms (usually when looking to exclude urinary tract infection) and sometimes in asymptomatic children. The majority of children fall into the latter two groups, the finding is temporary and not associated with long term renal disease. If the finding is persistent or patients have specific clinical features then renal abnormalities are more frequent and appropriate investigation is required. This review provides a rationale for an approach that allows reassurance to be given to children and their families in whom the finding is transient and benign, whilst identifying those in whom renal abnormalities are present and treatment required. It describes algorithms for macroscopic haematuria (MaH), asymptomatic microscopic haematuria (MiH) and proteinuria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
74. Examining chronic kidney disease screening frequency among diabetics: a POMDP approach.
- Author
-
Wu, Chou-Chun, Cao, Yiwen, Suen, Sze-chuan, and Lin, Eugene
- Subjects
CHRONIC kidney failure ,MEDICAL screening ,QUALITY-adjusted life years ,RACE ,BLACK people - Abstract
Forty percent of diabetics will develop chronic kidney disease (CKD) in their lifetimes. However, as many as 50% of these CKD cases may go undiagnosed. We developed screening recommendations stratified by age and previous test history for individuals with diagnosed diabetes and unknown proteinuria status by race and gender groups. To do this, we used a Partially Observed Markov Decision Process (POMDP) to identify whether a patient should be screened at every three-month interval from ages 30-85. Model inputs were drawn from nationally-representative datasets, the medical literature, and a microsimulation that integrates this information into group-specific disease progression rates. We implement the POMDP solution policy in the microsimulation to understand how this policy may impact health outcomes and generate an easily-implementable, non-belief-based approximate policy for easier clinical interpretability. We found that the status quo policy, which is to screen annually for all ages and races, is suboptimal for maximizing expected discounted future net monetary benefits (NMB). The POMDP policy suggests more frequent screening after age 40 in all race and gender groups, with screenings 2-4 times a year for ages 61-70. Black individuals are recommended for screening more frequently than their White counterparts. This policy would increase NMB from the status quo policy between $1,000 to $8,000 per diabetic patient at a willingness-to-pay of $150,000 per quality-adjusted life year (QALY). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
75. Renal alterations in cats (Felis catus) housed in shelters and affected by systemic AA-amyloidosis: Clinicopathological data, histopathology, and ultrastructural features.
- Author
-
Ferri, Filippo, Ferro, Silvia, Benali, Silvia Lucia, Aresu, Luca, Muscardin, Lorenza, Porporato, Federico, Rossi, Francesco, Guglielmetti, Chiara, Gallo, Enrico, Palizzotto, Carlo, Callegari, Carolina, Ricagno, Stefano, Mazza, Maria, Coppola, Luigi Michele, Gerardi, Gabriele, Lavatelli, Francesca, Caminito, Serena, Mazzini, Giulia, Palladini, Giovanni, and Merlini, Giampaolo
- Subjects
CATS ,AMYLOID plaque ,CHRONIC kidney failure ,INTERSTITIAL nephritis ,BLOOD testing - Abstract
AA-amyloidosis is frequent in shelter cats, and chronic kidney disease is the foremost cause of death. The aims were to describe kidney laboratory and microscopic findings in shelter cats with AA-amyloidosis. Cats were included if kidney specimens were collected post-mortem and laboratory data were available within 6 months before death. Renal lesions were evaluated with optical and electron microscopy. Mass spectrometry was used to characterize amyloid. Nine domestic short-hair cats were included; 4 females and 5 males with a median age of 8 years (range = 2–13). All cats had blood analyses and urinalyses available. Serum creatinine concentrations were increased in 6 cats and symmetric dimethylarginine was increased in all of the cats. All of the cats had proteinuria. Eight of 9 cats had amyloid in the medulla, and 9 had amyloid in the cortex (glomeruli). All cats had amyloid in the interstitium. Six cats had concurrent interstitial nephritis and 1 had membranoproliferative glomerulonephritis. All cats had extrarenal amyloid deposits. Amyloid was AA in each case. In conclusion, renal deposition of amyloid occurs in both cortex and medulla in shelter cats and is associated with azotemia and proteinuria. Renal involvement of systemic AA-amyloidosis should be considered in shelter cats with chronic kidney disease. The cat represents a natural model of renal AA-amyloidosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
76. Non-Maleficence toward Young Kidney Donors: A Call for Stronger Ethical Standards and Associated Factors in Multidisciplinary Nephrology Teams.
- Author
-
Tarabeih, Mahdi and Na'amnih, Wasef
- Subjects
KIDNEY transplantation ,ORGAN donors ,CROSS-sectional method ,PROTEINURIA ,SCALE analysis (Psychology) ,CREATININE ,BODY mass index ,CRONBACH'S alpha ,T-test (Statistics) ,BENEVOLENCE ,HYPERTENSION ,DESCRIPTIVE statistics ,NEPHROLOGY ,CHRONIC kidney failure ,PATIENT satisfaction ,DATA analysis software ,HEALTH care teams ,PROFESSIONAL competence ,GLOMERULAR filtration rate - Abstract
Background: The rising frequency of live kidney donations is accompanied by growing ethical concerns as to donor autonomy, the comprehensiveness of disclosure, and donors' understanding of long-term consequences. Aim: To explore donors' satisfaction with the ethical competence of multi-professional nephrology teams regarding disclosure of donation consequences to live kidney donors. Methods: A cross-sectional study was performed among Israeli live kidney donors who had donated a kidney in two hospitals that belonged to the Ministry of Health's Transplantation Center one year after the donation, from December 2018 to December 2020. Data collection was conducted online and through face-to-face interviews with the donors in their native language (Hebrew or Arabic). Results: Overall, 91 live kidney donors aged 18–49 years were enrolled. Of those, 65.9% were males, and 54.9% were academic donors. Among the live kidney donors, 59.3% reported that the motivation behind the donation was a first-degree family member vs. 35.2% altruistic and 5.5% commercial. Only 13.2% reported that the provided disclosure adequately explained the possible consequences of living with a single kidney. Approximately 20% of the participants reported that the disclosure included information regarding their risk of developing ESRD, hypertension, and proteinuria. The donors reported a low mean of the index score that indicates a low follow-up by the physician after the donation (mean = 1.16, SD = 0.37). The mean GFR level was significantly lower in the post-donation period one year following a kidney donation (117.8 mL/min/1.73 m
2 ) compared with the pre-donation period (84.0 mL/min/1.73 m2 ), p < 0.001. Conclusion: Our findings display that donors' satisfaction with the ethical competence of multi-professional nephrology teams regarding the disclosure of donation consequences to live kidney donors is low. This study indicates that donors are at an increased risk of worsening kidney functions (creatinine and GFR), and BMI. Our findings underscore the imperative to advise donors that their condition may worsen over time and can result in complications; thus, they should be monitored during short and long-term follow-up periods. This study was not registered. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
77. Dietary Magnesium Intake and Proteinuria: Is There a Relationship?
- Author
-
Mohtashamian, Abbas, Mozaffari-Rad, Negar, Soleimani, Alireza, Akbari, Hossein, Arabi, Vahid, and Sharifi, Nasrin
- Abstract
The possible relationship between dietary magnesium status and proteinuria has been suggested by a number of previous studies. However, human studies on this association are limited. Therefore, the present study aimed to investigate the independent relationship between dietary magnesium intake and urinary protein excretion. The present study was a post hoc analysis of the previous randomized clinical trial that evaluated the effect of dietary phosphorus restriction on proteinuria. The baseline data of 90 participants with proteinuria and chronic kidney disease was used to measure the association between dietary magnesium intake and proteinuria. Participants were asked to record their 24-h food intake for three days a week in a questionnaire. Urinary protein to creatinine ratio (UPCR) in a random urine sample was measured to be a marker for proteinuria. Out of 90 patients included in the study, 47 were men and 43 were women. The mean ± standard deviation of age and body mass index were 59.05 ± 14.16 years and 29.02 ± 5.54 kg/m
2 , respectively. The patients' average daily dietary intake of energy and magnesium were 2183 kcal and 169.44 mg, respectively. A significant inverse correlation was found between the dietary intake of magnesium and UPCR (r = − 0.219, p = 0.042). This association remained significant even after adjusting for confounding variables (β = − 0.222, p = 0.028). The findings of the present study showed a significant inverse relationship between the magnesium intake and proteinuria. Although, the design of the current research was cross-sectional, it has provided a basis for conducting future longitudinal studies and trials to better elucidate such a relationship. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
78. Evaluation of placental bed uterine in L-NAMEinduced early-onset preeclampsia (EO-PE) like the rat model.
- Author
-
Fitriana, Fitriana, Soetrisno, Soetrisno, Sulistyowati, Sri, and Indarto, Dono
- Subjects
PLACENTA ,RESEARCH funding ,DATA analysis ,DESCRIPTIVE statistics ,RATS ,DISEASES ,CONTROL groups ,PRE-tests & post-tests ,PREECLAMPSIA ,ANIMAL experimentation ,ONE-way analysis of variance ,STATISTICS ,NITRIC-oxide synthases ,MICROSCOPY ,CONFIDENCE intervals ,DATA analysis software ,UTERUS - Abstract
Copyright of Turkish Journal of Obstetrics & Gynecology is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
79. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus.
- Author
-
Jonny, Jonny, Sitepu, Enda Cindylosa, Lister, I Nyoman Ehrich, Chiuman, Linda, and Putranto, Terawan Agus
- Subjects
TYPE 2 diabetes ,DENDRITIC cells ,CHRONIC kidney failure ,DISEASE progression ,IMMUNE response ,DIABETIC nephropathies - Abstract
A typical consequence of type 2 diabetes mellitus, diabetic kidney disease (DKD) is a significant risk factor for end-stage renal disease. The pathophysiology of diabetic kidney disease (DKD) is mainly associated with the immune system, which involves adhesion molecules and growth factors disruption, excessive expression of inflammatory mediators, decreased levels of anti-inflammatory mediators, and immune cell infiltration in the kidney. Dendritic cells are professional antigen-presenting cells acting as a bridge connecting innate and adaptive immune responses. The anti-inflammatory subset of DCs is also capable of modulating inflammation. Autologous anti-inflammatory dendritic cells can be made by in vitro differentiation of peripheral blood monocytes and utilized as a cell-based therapy. Treatment with anti-inflammatory cytokines, immunosuppressants, and substances derived from pathogens can induce tolerogenic or anti-inflammatory features in ex vivo–generated DCs. It has been established that targeting inflammation can alleviate the progression of DKD. Recent studies have focused on the potential of dendritic cell–based therapies to modulate immune responses favorably. By inducing a tolerogenic phenotype in dendritic cells, it is possible to decrease the inflammatory response and subsequent kidney damage. This article highlights the possibility of using anti-inflammatory DCs as a cell-based therapy for DKD through its role in controlling inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
80. Health Impacts of Pre-eclampsia: A Comprehensive Analysis of Maternal and Neonatal Outcomes.
- Author
-
Socol, Flavius George, Bernad, Elena, Craina, Marius, Abu-Awwad, Simona-Alina, Bernad, Brenda-Cristiana, Socol, Ioana Denisa, Abu-Awwad, Ahmed, Farcas, Simona Sorina, Pop, Daniel Laurențiu, Gurgus, Daniela, and Andreescu, Nicoleta Ioana
- Subjects
LOW birth weight ,MENTAL illness ,PREGNANCY complications ,PREMATURE labor ,NEONATOLOGY ,ECLAMPSIA - Abstract
Background and Objectives: Hypertensive disorders, particularly pre-eclampsia, pose significant risks during pregnancy, affecting both maternal and neonatal health. The study aims to analyze short- and long-term health implications for mothers and their children, comparing those with pre-eclampsia to those without, to improve understanding of risk factors, diagnostic markers, and outcomes. Materials and Methods: This retrospective observational study involved 235 patients, 98 with pre-eclampsia and 137 without, monitored from 2015 to 2018 at the Obstetrics and Gynecology Department of the "Pius Brînzeu" Emergency County Clinical Hospital in Timișoara, Romania. Results: Women with pre-eclampsia were older, had higher BMIs, and more frequently had a family history of pre-eclampsia, hypertension, and diabetes. They also had lower educational and socioeconomic levels and fewer prenatal visits. Biochemical markers such as higher proteinuria, elevated sFlt-1, and lower PlGF were significant in diagnosing pre-eclampsia. Short-term maternal complications like eclampsia, HELLP syndrome, and acute kidney injury were more prevalent in the pre-eclampsia group. Neonatal outcomes included higher rates of preterm birth, low birth weight, and NICU admissions. Long-term mothers with a history of pre-eclampsia had higher incidences of chronic hypertension, cardiovascular disease, kidney problems, diabetes, and mental health disorders. Their children faced increased risks of neuropsychological delays, chronic respiratory issues, behavioral disorders, learning difficulties, and frequent infections. Conclusions: The study highlights the significant short- and long-term health impacts of pre-eclampsia on both mothers and their children. Early monitoring, intervention, and comprehensive management are crucial in mitigating these risks. These findings underscore the need for personalized care strategies to improve health outcomes for affected individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
81. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study.
- Author
-
Rui, Min, Jiang, Lei, Pan, Jia-Jun, Huang, Xue-Ting, Cui, Jia-Fang, Zhang, Shi-Jia, He, Su-Mei, Han, Huan-Huan, Chen, Xiao, and Wang, Dong-Dong
- Abstract
Purpose: The present study aims to explore the effects of tacrolimus on proteinuria in patients with idiopathic membranous nephropathy (IMN) and recommend an appropriate dosage schedule via machine learning method. Methods: The E
max model was constructed to analyze the effects of tacrolimus on proteinuria in patients with IMN. Data were mined from published literature and machine learning was built up with Emax model, among which the efficacy indicator was proteinuria change rates from baseline. 463 IMN patients were included for modeling, and tacrolimus therapeutic window concentrations were 4–10 ng/ml. Results: In machine learning model, the Emax from tacrolimus effecting proteinuria in IMN patients was −72.7%, the ET50 was 0.43 months, and the time to achieving 25% Emax , 50% Emax , 75% Emax , and 80% (plateau) Emax of tacrolimus on proteinuria in patients with IMN were 0.15, 0.43, 1.29, and 1.72 months, respectively. Conclusion: For achieving better therapeutic effects from tacrolimus on proteinuria in patients with IMN, tacrolimus concentration range need to be maintained at 4–10 ng/ml for at least 1.72 months. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
82. Contemporary review of IgA nephropathy.
- Author
-
Filippone, Edward J., Gulati, Rakesh, and Farber, John L.
- Subjects
COMPLEMENT inhibition ,KIDNEY failure ,COMPLEMENT activation ,IMMUNE complexes ,HEMATURIA ,IGA glomerulonephritis - Abstract
IgA nephropathy (IgAN) is considered the most common primary glomerulonephritis worldwide with a predilection for Asian-Pacific populations and relative rarity in those of African descent. Perhaps 20%-50% of patients progress to kidney failure. The pathogenesis is incompletely understood. Mesangial deposition of immune complexes containing galactose-deficient IgA1 complexed with anti-glycan IgG or IgA antibodies results in mesangial cell activation and proliferation, inflammatory cell recruitment, complement activation, and podocyte damage. Diagnosis requires a biopsy interpreted by the Oxford criteria. Additional pathologic features include podocytopathy, thrombotic microangiopathy, and C4d staining. Biomarkers predicting adverse outcomes include proteinuria, reduced GFR, hypertension, and pathology. Acceptable surrogate endpoints for therapeutic trials include ongoing proteinuria and rate of eGFR decline. The significance of persisting hematuria remains uncertain. The mainstay of therapy is supportive, consisting of lifestyle modifications, renin-angiotensin inhibition (if hypertensive or proteinuric), sodium-glucose-transporter 2 inhibition (if GFR reduced or proteinuric), and endothelin-receptor antagonism (if proteinuric). Immunosuppression should be considered for those at high risk after maximal supportive care. Corticosteroids are controversial with the most positive results observed in Chinese. They carry a high risk of serious side effects. Similarly, mycophenolate may be most effective in Chinese. Other immunosuppressants are of uncertain benefit. Tonsillectomy appears efficacious in Japanese. Active areas of investigation include B-cell inhibition with agents targeting the survival factors BAFF and APRIL and complement inhibition with agents targeting the alternate pathway (Factors B and D), the lectin pathway (MASP-2), and the common pathway (C3 and C5). Hopefully soon, the who and the how of immunosuppression will be clarified, and kidney failure can be forestalled. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
83. Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study.
- Author
-
Nihei, Satoru, Asaka, Junichi, Yaegashi, Mizunori, Asahi, Koichi, and Kudo, Kenzo
- Subjects
SYSTOLIC blood pressure ,REGRESSION analysis ,COLORECTAL cancer ,PROTEINURIA ,CANCER patients - Abstract
Purpose: Pre-existing hypertension is reportedly a major risk factor for bevacizumab-induced proteinuria. However, few studies have focused on the effects of blood pressure (BP) control on proteinuria during bevacizumab treatment. We report a retrospective study of the association between poor BP control and the risk of developing proteinuria in patients with colorectal cancer (CRC). Methods: Data for CRC patients who received bevacizumab between April 2015 and March 2022 were retrospectively collected. Patients were categorized into two groups based on average systolic blood pressure (SBP) during treatment: normal SBP (< 140 mmHg) and high SBP (≥ 140 mmHg). To evaluate the association between average SBP and grade ≥ 2 proteinuria, we used a 3 month landmark analysis and a Cox regression model. Results: Of the 279 patients analyzed, 109 had high SBP and 170 had normal SBP. The cumulative incidence of grade ≥ 2 and severe proteinuria was significantly higher in the high compared to the normal SBP group (p < 0.001 and p = 0.028, respectively). Landmark analysis indicated significant differences in proteinuria between patients with and without high average SBP during the first 3 months of treatment (p = 0.002 and p = 0.015, respectively). Multivariate analysis showed that average SBP ≥ 140 mmHg was a significant independent risk factor for proteinuria (p = 0.008). Conclusion: Landmark analysis showed that BP status during the first 3 months of bevacizumab treatment influences the risk of subsequent proteinuria. Therefore, timely diagnosis and stricter BP control are recommended for at least the first 3 months to avoid severe proteinuria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
84. Improved Proteinuria May Attenuate the Risk of Atrial Fibrillation: A Nationwide Population-Based Cohort Study.
- Author
-
Chang, Yoonkyung, Kang, Min Kyoung, and Song, Tae-Jin
- Subjects
- *
ATRIAL fibrillation , *PERIODIC health examinations , *KIDNEY diseases , *DISEASE incidence , *PROTEINURIA - Abstract
Background/Objectives: Proteinuria is documented as a risk factor for atrial fibrillation (AF) and can manifest in either reversible or continued forms. Our objective was to examine the relationship between the change in status for proteinuria and the risk of AF in a longitudinal cohort study on the general population nationwide. Methods: We included participants (n = 1,708,103) who underwent repetitive health examinations. The presence of proteinuria was determined by dipstick urinalysis results. The outcome was the occurrence of AF (International Classification of Diseases-10 code: I48). Results: All included participants, 1,666,111 (97.5%), 17,659 (1.0%), 19,696 (1.2%), and 4637 (0.3%), were categorized into groups of proteinuria-free, improved, progressed, and persistent, respectively. During a median follow-up of 14.5 years, 41,190 (2.4%) cases of AF occurred. In the multivariable analysis, the risk of AF was increased as the initial severity was more severe in the proteinuria-improved and proteinuria-persistent groups (p for trend < 0.001). In a further pairwise comparison, the proteinuria-improved group had a relatively lower risk of AF compared to the proteinuria-persistent group (HR: 0.751, 95% CI: 0.652–0.865, p < 0.001). Conclusions: Our study showed that the risk of AF can change according to alterations in proteinuria status. Notably, recovering from proteinuria can also be considered a modifiable risk factor for AF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
85. Incident Proteinuria by HIV Serostatus Among Men With Pre-–Diabetes Mellitus: The Multicenter AIDS Cohort Study.
- Author
-
Slama, Laurence, Barrett, Benjamin W, Abraham, Alison G, Palella, Frank J, Magnani, Jared W, Viard, Jean Paul, Lake, Jordan E, and Brown, Todd T
- Subjects
- *
HIV infection complications , *BLOOD sugar analysis , *PREDIABETIC state , *PROTEINURIA , *RISK assessment , *LAMIVUDINE , *HIV integrase inhibitors , *RENIN-angiotensin system , *GLYCOSYLATED hemoglobin , *CREATININE , *RESEARCH funding , *BLOOD proteins , *CD4 lymphocyte count , *DESCRIPTIVE statistics , *HIV infections , *LONGITUDINAL method , *PROTEASE inhibitors , *MEN'S health , *RESEARCH , *SODIUM-glucose cotransporter 2 inhibitors , *CONFIDENCE intervals , *DISEASE incidence , *DIABETES , *DISEASE risk factors , *DISEASE complications - Abstract
Background Pre–diabetes mellitus (DM) is associated with proteinuria, a risk factor for chronic kidney disease. While people with human immunodeficiency virus (HIV; PWH) have a higher risk of proteinuria than people without HIV (PWOH), it is unknown whether incident proteinuria differs by HIV serostatus among prediabetic persons. Methods The urine protein-to-creatinine ratio was measured at semiannual visits among men in the Multicenter AIDS Cohort Study since April 2006. Men with pre-DM on or after April 2006 and no prevalent proteinuria or use of antidiabetic medications were included. Pre-DM was defined as a fasting glucose level of 100–125 mg/dL confirmed within a year by a repeated fasting glucose or hemoglobin A1c measurement of 5.7%–6.4%. Incident proteinuria was defined as a urine protein-to-creatinine ratio (UPCR) >200 mg/g, confirmed within a year. We used Poisson regression models to determine whether incident proteinuria in participants with pre-DM differed by HIV serostatus and, among PWH, whether HIV-specific factors were related to incident proteinuria. Results Between 2006 and 2019, among 1276 men with pre-DM, proteinuria developed in 128 of 613 PWH (21%) and 50 of 663 PWOH (8%) over a median 10-year follow-up. After multivariable adjustment, the incidence of proteinuria in PWH with pre-DM was 3.3 times (95% confidence interval, 2.3–4.8 times) greater than in PWOH (P <.01). Among PWH, current CD4 cell count <50/µL (P <.01) and current use of protease inhibitors (P =.03) were associated with incident proteinuria, while lamivudine and integrase inhibitor use were associated with a lower risk. Conclusions Among men with pre-DM, the risk of incident proteinuria was 3 times higher in PWH. Strategies to preserve renal function are needed in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
86. A new perspective on proteinuria and drug therapy for diabetic kidney disease.
- Author
-
Ruimin Zhang, Qian Wang, Yaqing Li, Qihu Li, Xuefeng Zhou, Xiangmei Chen, and Zheyi Dong
- Subjects
DIABETIC nephropathies ,CHRONIC kidney failure ,MINERALOCORTICOID receptors ,ALBUMINURIA ,CARDIOVASCULAR diseases ,ENDOTHELIN receptors - Abstract
Diabetic kidney disease (DKD) is one of the leading causes of end-stage renal disease worldwide and significantly increases the risk of premature death due to cardiovascular diseases. Elevated urinary albumin levels are an important clinical feature of DKD. Effective control of albuminuria not only delays glomerular filtration rate decline but also markedly reduces cardiovascular disease risk and all-cause mortality. New drugs for treating DKD proteinuria, including sodium-glucose cotransporter two inhibitors, mineralocorticoid receptor antagonists, and endothelin receptor antagonists, have shown significant efficacy. Auxiliary treatment with proprietary Chinese medicine has also yielded promising results; however, it also faces a broader scope for development. The mechanisms by which these drugs treat albuminuria in patients with DKD should be described more thoroughly. The positive effects of combination therapy with two or more drugs in reducing albuminuria and protecting the kidneys warrant further investigation. Therefore, this review explores the pathophysiological mechanism of albuminuria in patients with DKD, the value of clinical diagnosis and prognosis, new progress and mechanisms of treatment, and multidrug therapy in patients who have type 2 diabetic kidney disease, providing a new perspective on the clinical diagnosis and treatment of DKD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
87. Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.
- Author
-
Cai, Anxiang, Meng, Yiwei, Zhou, Hang, Cai, Hong, Shao, Xinghua, Wang, Qin, Xu, Yao, Zhou, Yin, Zhou, Wenyan, Chen, Luonan, and Mou, Shan
- Subjects
- *
BONE morphogenetic proteins , *RNA sequencing , *RENAL biopsy , *CHRONIC kidney failure , *BASAL lamina - Abstract
Primary membranous nephropathy (PMN) is one of the leading causes of end‐stage renal disease, and the most frequent cause of massive proteinuria in nondiabetic adults, resulting in fatal complications. However, the underlying pathomechanisms of PMN remain largely unclear. Here, single‐cell RNA sequencing is employed to analyze kidney biopsies from eleven PMN patients and seven healthy subjects. Profiling 44 060 cells from patients allowed us to characterize the cellular composition and cell‐type‐specific gene expression in the PMN kidney. The complement‐induced BMP2/pSMAD1/COL4 pathway is identified as the pathogenic pathway in podocytes, bridging two key events, i.e., complement system activation and glomerular basement membrane thickening in PMN. Augmented infiltration and activation of myeloid leukocytes and B lymphocytes are found, profiling delicate crosstalk of immune cells in PMN kidneys. Overall, these results provide valuable insights into the roles of podocytes and immune cells in PMN, and comprehensive resources toward the complete understanding of PMN pathophysiology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
88. Prognostic Indicators in Chronic Kidney Disease: A Comprehensive Analysis of 24-hour Urinary Protein, eGFR, Uric Acid, Renal Pathology, and Direct Immunofluorescence Findings.
- Author
-
Upadhyay, Nirali M., Sahu, Shilpi, Nayak, Aditya, Jadhav, Priyanka, and Purohit, Keyuri
- Subjects
- *
DIABETIC nephropathies , *CHRONIC kidney failure , *KIDNEY diseases , *URIC acid , *GLOMERULAR filtration rate - Abstract
This study evaluates the prognostic significance of various biomarkers in chronic kidney disease (CKD) among 50 patients, focusing on sex prevalence, case distribution, age group distribution according to final diagnosis, proteinuria severity, and the impact of tubulointerstitial nephritis (TIN). The findings reveal a higher prevalence of CKD in males (58%) compared to females (42%), with diabetic nephropathy(DN) being the most common diagnosis (34%). Severe proteinuria was notably higher in conditions like DN and membranoproliferative glomerulonephritis(MPGN). TIN was associated with significant reductions in estimated glomerular filtration rate (eGFR), indicating severe renal impairment. Correlation analyses showed a strong negative relationship between serum creatinine and eGFR (-0.67), and a positive correlation between serum creatinine and uric acid levels (0.24), indicating reduced kidney function with higher creatinine levels. Direct immunofluorescence (DIF), particularly C3c positivity, played a crucial role in confirming diagnoses and was linked to higher levels of uric acid and 24-hour urine protein, suggesting more severe disease. These insights underscore the importance of integrating traditional biochemical markers with advanced immunopathological techniques for comprehensive CKD diagnosis and management, ultimately aiming to improve patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
89. Long-term outcomes of patients with IgA nephropathy in the German CKD cohort.
- Author
-
Stamellou, Eleni, Nadal, Jennifer, Hendry, Bruce, Mercer, Alex, Seikrit, Claudia, Bechtel-Walz, Wibke, Schmid, Matthias, Moeller, Marcus J, Schiffer, Mario, Eckardt, Kai-Uwe, Kramann, Rafael, Floege, Jürgen, and investigators, the GCKD study
- Subjects
- *
MAJOR adverse cardiovascular events , *RENAL replacement therapy , *PROPORTIONAL hazards models , *IGA glomerulonephritis , *CHRONIC kidney failure - Abstract
Background The importance of albuminuria as opposed to proteinuria in predicting kidney outcomes in primary immunoglobulin A nephropathy (IgAN) is not well established. Methods From 2010 to 2012, 421 patients with biopsy-proven IgAN have been enrolled into the German Chronic Kidney Disease (GCKD) cohort, a prospective observational cohort study (N = 5217). Adjudicated endpoints include a composite kidney endpoint (CKE) consisting of eGFR decline >40%, eGFR <15 ml/min/1.73 m2 and initiation of kidney replacement therapy; the individual components of the CKE; and combined major adverse cardiac events (MACE), including non-fatal myocardial infarction, non-fatal stroke and all-cause mortality. The associations between the incidence of CKE and baseline factors, including demographics, laboratory values and comorbidities were analysed using the Cox proportional hazards regression model. Results The mean age of IgAN patients at baseline was 51.6 years (± 13.6) and 67% were male. The patient-reported duration of disease at baseline was 5.9 ± 8.1 years. Baseline median urine albumin:creatinine ratio (UACR) was 0.4 g/g [interquartile range (IQR) 0.1–0.8] and mean eGFR was 52.5 ± 22.4 ml/min/1.73 m2. Over a follow-up of 6.5 years, 64 (15.2%) patients experienced a >40% eGFR decline, 3 (0.7%) reached eGFR <15 ml/min/1.73 m2, 53 (12.6%) initiated kidney replacement therapy and 28% of the patients experienced the CKE. Albuminuria, with reference to <0.1 g/g, was most associated with CKE. Hazard ratios (HRs) at UACRs of 0.1–0.6 g/g, 0.6–1.4 g/g, 1.4–2.2 g/g and >2.2 g/g were 2.03 [95% confidence interval (CI) 1.02–4.05], 3.8 (95% CI 1.92–7.5), 5.64 (95% CI 2.58–12.33) and 5.02 (95% CI 2.29–11-03), respectively. Regarding MACE, the presence of diabetes [HR 2.53 (95% CI 1.11–5.78)] was the most strongly associated factor, whereas UACR and eGFR did not show significant associations. Conclusion In the GCKD IgAN subcohort, more than every fourth patient experienced a CKE event within 6.5 years. Our findings support the use of albuminuria as a surrogate to assess the risk of poor kidney outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
90. Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases.
- Author
-
Alkaff, Firas F, Lammerts, Rosa G M, Daha, Mohamed R, Berger, Stefan P, and van den Born, Jacob
- Subjects
- *
RENAL fibrosis , *KIDNEY failure , *KIDNEY diseases , *COMPLEMENT activation , *KIDNEY tubules - Abstract
Many kidney diseases are associated with proteinuria. Since proteinuria is independently associated with kidney function loss, anti-proteinuric medication, often in combination with dietary salt restriction, comprises a major cornerstone in the prevention of progressive kidney failure. Nevertheless, complete remission of proteinuria is very difficult to achieve, and most patients with persistent proteinuria slowly progress toward kidney failure. It is well-recognized that proteinuria leads to kidney inflammation and fibrosis via various mechanisms. Among others, complement activation at the apical side of the proximal tubular epithelial cells is suggested to play a crucial role as a cause of progressive loss of kidney function. However, hitherto limited attention is given to the pathophysiological role of tubular complement activation relative to glomerular complement activation. This review aims to summarize the evidence for tubular epithelial complement activation in proteinuric kidney diseases in relation to loss of kidney function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
91. Mineralocorticoid receptor antagonists in kidney transplantation.
- Author
-
Kanbay, Mehmet, Copur, Sidar, Mizrak, Berk, Mallamaci, Francesca, and Zoccali, Carmine
- Subjects
- *
MINERALOCORTICOID receptors , *KIDNEY transplantation , *ANGIOTENSIN-receptor blockers , *ACE inhibitors , *CHRONIC kidney failure - Abstract
Background: The fundamental role of the renin–angiotensin–aldosterone system in the pathophysiology of chronic kidney disease, congestive heart failure, hypertension and proteinuria is well established in pre‐clinical and clinical studies. Mineralocorticoid receptor antagonists are among the primary options for renin–angiotensin–aldosterone system blockage, along with angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers. Methods: In this narrative review, we aim to evaluate the efficiency and safety of mineralocorticoid receptor antagonists in kidney transplant recipients, including the potential underlying pathophysiology. Results: The efficiency and safety of mineralocorticoid receptor antagonists in managing chronic kidney disease and proteinuria, either non‐nephrotic or nephrotic range, have been demonstrated among nontransplanted patients, though studies investigating the role of mineralocorticoid receptor antagonists among kidney transplant recipients are scarce. Nevertheless, promising results have been reported in pre‐clinical and clinical studies among kidney transplant recipients regarding the role of mineralocorticoid receptor antagonists in terms of ischaemia–reperfusion injury, proteinuria, or calcineurin inhibitor‐mediated nephrotoxicity without considerable adverse events such as hypotension, hyperkalaemia or worsening renal functions. Conclusion: Even though initial results regarding the role of mineralocorticoid receptor antagonist therapy for kidney transplant recipients are promising, there is clear need for large‐scale randomized clinical trials with long‐term follow‐up data. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
92. The interval between the onset of increased blood pressure and proteinuria in preeclampsia and the contributing factors.
- Author
-
Ren, Jie, Zhao, Caiyun, Fan, Zhuoran, Wang, Yanli, Sheng, Hongna, and Hua, Shaofang
- Subjects
- *
BLOOD pressure , *DIASTOLIC blood pressure , *HYPERTENSION , *PREECLAMPSIA , *PROTEINURIA , *PLACENTA diseases - Abstract
Purpose: New-onset proteinuria, as a pivotal sign of representative renal lesions in preeclampsia, is still the most common diagnostic tool for this condition and has been proven to be related to a significantly abnormal sFlt-1/VEGF ratio in circulation. At the same time, blood pressure control plays a vital role in the occurrence and evolution of proteinuria. Therefore, it is particularly helpful to investigate their interval, not only for performing urinalysis for protein more accurately but also for evaluating blood pressure as well as the aggravation of illness, as the related research is limited. Methods: This retrospective study included 515 preeclampsia patients and 358 normotensive pregnant women who labored in the Second Hospital of Tianjin Medical University from January 2016 to January 2020. First, we described the onset circumstance of high blood pressure and proteinuria as well as the interval among the case group and the subgroups. Then, we determined whether there were significant differences in the basic information, laboratory test results, and newborns between the case and normal groups. Finally, multifactor ANOVA was used to determine the factors influencing the interval. Results: 1. The two most common complications in preeclampsia were proteinuria (88.35%) and placental dysfunction (5.05%). Moreover, 72.04% of preeclampsia cases were diagnosed by abnormal blood pressure together with new-onset proteinuria. 2. The average interval between high blood pressure and proteinuria was 22 gestational days (from 0 to 106 days), and this interval was not significantly different between mild and severe PE (26 days vs. 21 days, P > 0.05) but significantly differed between early-onset and late-onset PE (9 days vs. 28 days, P < 0.05). 3. The number of prenatal visits, serum creatinine in the early trimester, gestational time and diastolic blood pressure value when increased blood pressure was initially detected may influence the interval between the onset of increased blood pressure and proteinuria. Conclusion: New-onset proteinuria was still the main parameter for identifying preeclampsia. The interval between increased blood pressure and proteinuria was probably related to the imbalance in the sFlt-1/VEGF ratio; therefore, we should pay attention to monitor proteinuria during the prenatal visits, especially for patients with a lower frequency of prenatal visits, higher serum creatinine in the early trimester, earlier onset and higher diastolic blood pressure at the initial onset of increased blood pressure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
93. Obstetrical outcomes of women with new-onset isolated proteinuria diagnosed after 24 weeks' gestation.
- Author
-
Sgayer, Inshirah, Cohen, Milton, Rosenbaum, Yarden, Kruzel-Davila, Etty, Shasha-Lavsky, Hadas, Lowenstein, Lior, and Wolf, Maya Frank
- Subjects
- *
NEONATAL intensive care units , *PROTEINURIA , *MULTIPLE pregnancy , *PREMATURE labor , *PREGNANCY - Abstract
Purpose: To assess a possible association between marked proteinuria and the risk of preeclampsia with severe features, as defined by the American College of Obstetricians and Gynecologists. Methods: This retrospective study included data recorded at a tertiary university-affiliated hospital between 2017 and 2022. Women at or beyond 24 weeks of gestation with proteinuria (protein levels > 300 mg in a 24 h urine collection) and normal blood pressure during the initial 48 h of admission were included. Obstetrical and neonatal outcomes were compared between women with mild proteinuria (300–1000 mg/24 h) and marked proteinuria (≥ 1000 mg/24 h). Results: Among the women with marked proteinuria (n = 48) compared to those with mild proteinuria (n = 108), the incidences were higher of preeclampsia (50.0% vs. 22.2%, p = 0.001) and of preeclampsia with severe features (18.8% vs. 2.8%, p < 0.001). In multivariate analysis that adjusted for maternal age, primiparity, multiple pregnancy, uric acid level > 6 mg/dL and aspirin treatment, marked proteinuria was a risk factor for preeclampsia with severe features (adjusted odds ratio [aOR] = 10.2, confidence interval [CI] 95% 1.9–54.0, p = 0.007) and for small-for-gestational-age infants (aOR = 2.4, 95% CI 1.02–5.6, p = 0.001). Among women with marked compared to mild proteinuria, rates were also higher of labor induction (58.3% vs. 25.9%, p < 0.001), indicated preterm delivery (41.7% vs. 25.0%, p = 0.04) and admission to the neonatal intensive care unit (44.1% vs. 25.8%, p = 0.017). Conclusions: Women with marked compared to mild isolated proteinuria showed higher risk of developing preeclampsia with severe features and of delivering small-for-gestational-age neonates. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
94. Clinical algorithms for the management of intrapartum maternal urine abnormalities.
- Author
-
Cheung, KW, Tan, LN, Meher, S, Ciabati, Livia, Oliveira, Lariza Laura De, Souza, Renato, Browne, Joyce, Rijken, Marcus, Fawcus, Sue, Hofmeyr, Justus, Liabsuetrakul, Tippawan, GÜLÜMSER, Çağri, Blennerhassett, Anna, Lissauer, David, Meher, Shireen, Althabe, Fernando, Bonet, Mercedes, Metin Gülmezoglu, A, and Oladapo, Olufemi
- Subjects
- *
MEDICAL personnel , *HEALTH facilities , *MEDICAL protocols , *INTRAPARTUM care , *PUERPERIUM - Abstract
Aim: To develop evidence‐based clinical algorithms for management of common intrapartum urinary abnormalities. Population: Women with singleton, term pregnancies in active labour and immediate postnatal period, at low risk of complications. Setting: Healthcare facilities in low‐ and middle‐income countries. Search strategy: A systematic search and review were conducted on the current guidelines from WHO, NICE, ACOG and RCOG. Additional search was done on PubMed and The Cochrane Database of Systematic Reviews up to May 2020. Case scenarios: Four common intrapartum urinary abnormalities were selected: proteinuria, ketonuria, glycosuria and oliguria. Using reagent strip testing, glycosuria was defined as ≥2+ on one occasion or of ≥1+ on two or more occasions. Proteinuria was defined as ≥2+ and presence of ketone indicated ketonuria. Oliguria was defined as hourly urine output ≤30 ml. Thorough initial assessment using history, physical examination and basic investigations helped differentiate most of the underlying causes, which include diabetes mellitus, dehydration, sepsis, pre‐eclampsia, shock, anaemia, obstructed labour, underlying cardiac or renal problems. A clinical algorithm was developed for each urinary abnormality to facilitate intrapartum management and referral of complicated cases for specialised care. Conclusions: Four simple, user‐friendly and evidence‐based clinical algorithms were developed to enhance intrapartum care of commonly encountered maternal urine abnormalities. These algorithms may be used to support healthcare professionals in clinical decision‐making when handling normal and potentially complicated labour, especially in low resource countries. Evidence‐based clinical algorithms developed to guide intrapartum management of commonly encountered urinary abnormalities. An evidence‐based clinical algorithm was developed to enhance intrapartum management of commonly encountered urinary abnormalities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
95. Are children with IgA nephropathy different from adult patients?
- Author
-
Su, Baige, Jiang, Yuanyuan, Li, Zhihui, Zhou, Jianhua, Rong, Liping, Feng, Shipin, Zhong, Fazhan, Sun, Shuzhen, Zhang, Dongfeng, Xia, Zhengkun, Feng, Chunyue, Huang, Wenyan, Li, Xiaoyan, Chen, Chaoying, Hao, Zhihong, Wang, Mo, Qin, Li, Chen, Minguang, Li, Yuanyuan, and Ding, Juanjuan
- Subjects
- *
TREATMENT of glomerulonephritis , *PROTEINURIA , *STEROIDS , *RESEARCH funding , *IMMUNOGLOBULINS , *HYPERTENSION , *SYMPTOMS , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *HEMATURIA , *DISEASE remission , *LONGITUDINAL method , *RESEARCH , *COMPARATIVE studies , *GLOMERULAR filtration rate , *GLUCOCORTICOIDS , *CHILDREN , *ADULTS - Abstract
Background: Previously, several studies have indicated that pediatric IgA nephropathy (IgAN) might be different from adult IgAN, and treatment strategies might be also different between pediatric IgAN and adult IgAN. Methods: We analyzed two prospective cohorts established by pediatric and adult nephrologists, respectively. A comprehensive analysis was performed investigating the difference in clinical and pathological characteristics, treatment, and prognosis between children and adults with IgAN. Results: A total of 1015 children and 1911 adults with IgAN were eligible for analysis. More frequent gross hematuria (88% vs. 20%, p < 0.0001) and higher proteinuria (1.8 vs. 1.3 g/d, p < 0.0001) were seen in children compared to adults. In comparison, the estimated glomerular filtration rate (eGFR) was lower in adults (80.4 vs. 163 ml/min/1.73 m2, p < 0.0001). Hypertension was more prevalent in adult patients. Pathologically, a higher proportion of M1 was revealed (62% vs. 39%, p < 0.0001) in children than in adults. S1 (62% vs. 28%, p < 0.0001) and T1–2 (34% vs. 8%, p < 0.0001) were more frequent in adults. Adjusted by proteinuria, eGFR, and hypertension, children were more likely to be treated with glucocorticoids than adults (87% vs. 45%, p < 0.0001). After propensity score matching, in IgAN with proteinuria > 1 g/d, children treated with steroids were 1.87 (95% CI 1.16–3.02, p = 0.01) times more likely to reach complete remission of proteinuria compared with adults treated with steroids. Conclusions: Children present significantly differently from adults with IgAN in clinical and pathological manifestations and disease progression. Steroid response might be better in children. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
96. Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome.
- Author
-
Du, Rong, Zhou, Chengcheng, Chen, Shehong, Li, Tong, Lin, Yunting, Xu, Aijing, Huang, Yonglan, Mei, Huifen, Huang, Xiaoli, Tan, Dongdong, Zheng, Ruidan, Liang, Cuili, Cai, Yanna, Shao, Yongxian, Zhang, Wen, Liu, Li, and Zeng, Chunhua
- Subjects
- *
LOWE'S syndrome , *PROTEINURIA , *RESEARCH funding , *DIAGNOSTIC errors , *RETROSPECTIVE studies , *GENETIC variation , *GENE expression , *RESEARCH , *MEDICAL records , *ACQUISITION of data , *COGNITION disorders , *GENETIC mutation , *CASE studies , *PHENOTYPES , *GENETIC testing , *SEQUENCE analysis , *SYMPTOMS - Abstract
Background: Lowe syndrome is characterized by the presence of congenital cataracts, psychomotor retardation, and dysfunctional proximal renal tubules. This study presents a case of an atypical phenotype, investigates the genetic characteristics of eight children diagnosed with Lowe syndrome in southern China, and performs functional analysis of the novel variants. Methods: Whole-exome sequencing was conducted on eight individuals diagnosed with Lowe syndrome from three medical institutions in southern China. Retrospective collection and analysis of clinical and genetic data were performed, and functional analysis was conducted on the five novel variants. Results: In our cohort, the clinical symptoms of the eight Lowe syndrome individuals varied. One patient was diagnosed with Lowe syndrome but did not present with congenital cataracts. Common features among all patients included cognitive impairment, short stature, and low molecular weight proteinuria. Eight variations in the OCRL gene were identified, encompassing three previously reported and five novel variations. Among the novel variations, three nonsense mutations were determined to be pathogenic, and two patients harboring novel missense variations of uncertain significance exhibited severe typical phenotypes. Furthermore, all novel variants were associated with altered protein expression levels and impacted primary cilia formation. Conclusion: This study describes the first case of an atypical Lowe syndrome patient without congenital cataracts in China and performs a functional analysis of novel variants in the OCRL gene, thereby expanding the understanding of the clinical manifestations and genetic diversity associated with Lowe syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
97. Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.
- Author
-
Rosales, Alejandra, Kuppelwieser, Sarah, Giner, Thomas, Hofer, Johannes, Riedl Khursigara, Magdalena, Orth-Höller, Dorothea, Borena, Wegene, Cortina, Gerard, Jungraithmayr, Therese, and Würzner, Reinhard
- Subjects
- *
RISK assessment , *PROTEINURIA , *THERAPEUTICS , *RENAL replacement therapy , *RESEARCH funding , *BACTERIAL toxins , *HYPERTENSION , *HEMOLYTIC-uremic syndrome , *DESCRIPTIVE statistics , *HEMODIALYSIS , *CATASTROPHIC illness , *ESCHERICHIA coli diseases , *CONVALESCENCE , *CONFIDENCE intervals , *PATIENT aftercare , *GLOMERULAR filtration rate , *PLASMA exchange (Therapeutics) , *DISEASE risk factors , *DISEASE complications , *CHILDREN - Abstract
Background: Hemolytic uremic syndrome (HUS) is an important cause of acute kidney injury in children. HUS is known as an acute disease followed by complete recovery, but patients may present with kidney abnormalities after long periods of time. This study evaluates the long-term outcome of Shiga toxin-producing Escherichia coli-associated HUS (STEC-HUS) in pediatric patients, 10 years after the acute phase of disease to identify risk factors for long-term sequelae. Methods: Over a 6-year period, 619 patients under 18 years of age with HUS (490 STEC-positive, 79%) were registered in Austria and Germany. Long-term follow-up data of 138 STEC-HUS-patients were available after 10 years for analysis. Results: A total of 66% (n = 91, 95% CI 0.57–0.73) of patients fully recovered showing no sequelae after 10 years. An additional 34% (n = 47, 95% CI 0.27–0.43) presented either with decreased glomerular filtration rate (24%), proteinuria (23%), hypertension (17%), or neurological symptoms (3%). Thirty had sequelae 1 year after STEC-HUS, and the rest presented abnormalities unprecedented at the 2-year (n = 2), 3-year (n = 3), 5-year (n = 3), or 10-year (n = 9) follow-up. A total of 17 patients (36.2%) without kidney abnormalities at the 1-year follow-up presented with either proteinuria, hypertension, or decreased eGFR in subsequent follow-up visits. Patients needing extracorporeal treatments during the acute phase were at higher risk of presenting symptoms after 10 years (p < 0.05). Conclusions: Patients with STEC-HUS should undergo regular follow-up, for a minimum of 10 years following their index presentation, due to the risk of long-term sequelae of their disease. An initial critical illness, marked by need of kidney replacement therapy or plasma treatment may help predict poor long-term outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
98. Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients.
- Author
-
Ahmed, Alshymaa A, Said, Dina, and Sami, May M
- Subjects
- *
SYSTEMIC lupus erythematosus , *CONNECTIVE tissue diseases , *SYSTEMIC scleroderma , *KIDNEY diseases , *RENAL biopsy , *LUPUS nephritis - Abstract
Background: Renal impairments commonly occur as a complication of autoimmune connective tissue diseases (CTDs). Therefore, early nephritis prediction is vital for patient outcomes. Growth Arrest-Specific Protein 6 (GAS6) was found to be upregulated in many types of inflammatory renal disease, including diabetic nephropathy. Aim: To evaluate GAS6 as a predictor of renal impairment in adults with systemic sclerosis (SSc) and children with systemic lupus Erythematosus (SLE). Methods: The study included 60 patients with SSc and 40 children with SLE. The serum level of GAS6 was measured using the ELISA technique. In adults with SSc, total proteins in 24-h urine concentration of >300 mg/24 h indicated renal inflammation, while in children with SLE, nephritis was diagnosed by abnormal renal pathology. Results: In SSc patients, GAS6 significantly increased in patients with proteinuria. GAS6 is an independent predictor of nephritis with an odds ratio (OR) of 1.06 and a 95% confidence interval (CI) of 1.0-1.1. at cutoff 12.2 ng/mL GAS6 predicted proteinuria with sensitivity 86.7% (95% CI: 59.5% to 98.3%), specificity 57.8% (95% CI: 42.1% to 72.3%), positive predictive value 40.6% (95% CI: 31.5% to 50.4%), negative predictive value 92.9% (95% CI: 77.7% to 97.73%), and accuracy 65.0% (95% CI: 51.6% to 76.9%). In SLE patients, Serum GAS6 did not differ significantly between children with and without lupus nephritis. Conclusion: GAS6 is an independent predictor of nephritis in patients with SSc. However, there is no association between GAS6 and nephritis in juvenile patients with SLE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
99. Effect of antimalarials on clinical outcomes in lupus nephritis.
- Author
-
Peña-Vizcarra, Óscar R, Zavala-Miranda, María Fernanda, Juárez-Cuevas, Bernardo, Márquez-Macedo, Sofía E, Hernández-Andrade, Adriana, Nordmann-Gomes, Alberto, Pérez-Arias, Abril A, Morales-Buenrostro, Luis E, and Mejía-Vilet, Juan M
- Subjects
- *
KIDNEY disease risk factors , *KIDNEY disease prevention , *RISK assessment , *PROTEINURIA , *HYDROXYCHLOROQUINE , *LUPUS nephritis , *RESEARCH funding , *IMMUNOSUPPRESSIVE agents , *PATHOLOGIC complete response , *RETINAL diseases , *PROBABILITY theory , *TREATMENT effectiveness , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *LONGITUDINAL method , *MEDICAL records , *ACQUISITION of data , *ANTIMALARIALS , *DATA analysis software , *PROPORTIONAL hazards models , *EPIDERMAL growth factor receptors - Abstract
Objectives To evaluate the effect of antimalarial drugs in response to therapy, incidence of LN flares, and progression of kidney disease in a large LN cohort. Methods We retrospectively studied 424 biopsy-proven LN patients followed for >3 years. We obtained demographic, clinical, laboratory, histopathological and treatment variables. Antimalarial use was approached as (i) users vs no users, (ii) according to prevalent vs incident use regarding the LN flare and (iii) according to the type of antimalarial. All outcomes were evaluated by time-to-event analyses. Adjusted hazard ratios were obtained by Cox regression. Results The cohort included 424 patients, median age of 29 years (IQR 23–37), 96% female, with a median eGFR of 81 ml/min/1.73 m2 (IQR 48–118) and proteinuria of 3.4 g/g (IQR 1.9–5.5). Antimalarial use was associated with higher complete response (aHR 1.57, 1.08–2.27), lower incidence of kidney flares (aHR 0.63, 0.43–0.92) and lower progression to kidney failure (aHR 0.37, 0.23–0.53). The effect of antimalarials on these outcomes was modified by the presentation eGFR, histological class and/or concomitant initial immunosuppressor. These protective effects were observed in patients with prevalent or incident use regarding the LN flare and patients using hydroxychloroquine. The incidence of toxic retinopathy was 1.7%, 5.7% and 8.8% by 3, 5 and 7 years of continued antimalarial use, respectively. Conclusion The use of antimalarial drugs is associated with increased response to therapy, lower incidence of kidney flares, and lower progression to kidney failure in LN patients. Conversely, this population is at high risk of toxic maculopathy, and yearly ophthalmologic examination is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
100. Comparison of two methods of measuring the urinary protein concentration for the determination of the urinary protein to creatinine ratio in various animal species.
- Author
-
KOVARIKOVA, SIMONA, BLAHOVA, JANA, VANOVA, IVANA, and MARSALEK, PETR
- Subjects
- *
GUINEA pigs , *ANIMAL species , *DETECTION limit , *DOGS , *CATS - Abstract
Determination of the urinary protein-to-creatinine ratio (UPC) is an important tool in the quantification of proteinuria in animals. However, the result may be affected by the different methods of determining the urinary protein concentration. The aim of this study was to compare the turbidimetric method using benzethonium chloride and the colorimetric method using pyrogallol red in the measurement of the urinary protein concentration in dogs, cats, guinea pigs and horses. A total of 464, 192, 216 and 119 urine samples from dogs, cats, guinea pigs and horses were examined in the study, respectively. The group consisted of animals of both sexes and different ages, and, in the dogs and cats, it included both healthy animals and those with various health problems. In the group of horses and guinea pigs, only clinically healthy animals were included. A total of 347, 185, 103 and 100 samples from the dogs, cats, guinea pigs and horses were used in the statistical analysis; the other values were excluded as they were below the detection limit. According to the Passing-Bablok analysis, there was a significant constant and proportional difference in the horses. In the dogs, cats and guinea pigs, there was a significant constant difference, but no proportional difference. The Bland-Altman method showed significant bias between the two methods in the horses and cats, but not in the dogs and guinea pigs. In the dogs and cats, the agreement between the two methods was tested and expressed as Cohen’s kappa (κ). In the cats, it was almost perfect for the proteinuric samples (κ = 0.823 3) and significant for the non-proteinuric samples (κ = 0.804 9). In the dogs, the agreement was significant for the non-proteinuric samples (κ = 0.621 5) and only moderate for the proteinuric samples (κ = 0.527 5). The influence of the method used to determine the urinary protein concentration should be taken into account when evaluating the UPC. Repeated examinations in one patient should be performed with the same method. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.